期刊文献+

老年心力衰竭患者血清Ang-(1-7)、AngⅡ水平的变化 被引量:7

Serum Ang-(1-7) and AngⅡ levels in elderly patients with heart failure
下载PDF
导出
摘要 目的探讨老年心力衰竭患者血清中Ang-(1-7)、AngⅡ水平变化。方法入选北京友谊医院医保中心内科及心内科因失代偿心力衰竭住院的老年患者31例为心力衰竭组,对照组为性别、年龄、所患基础疾病与实验组相匹配的同期住院非心力衰竭病人。收集两组患者一般信息,采用酶联免疫吸附法测定血清Ang-(1-7)、AngⅡ的浓度。结果心力衰竭组血清Ang-(1-7)的水平(155.50±38.28 pg/ml)明显高于对照组(130.68±32.22 pg/ml),差异有统计学意义(P<0.05)。心力衰竭组患者血清AngⅡ的水平(1 346.95±236.90 pg/ml)明显高于对照组(1 190.17±122.52 pg/ml),差异有统计学意义(P<0.05)。结论 Ang-(1-7)可通过ACE2-Ang-(1-7)-MAS轴拮抗Ang II的作用,改善心肌重构,改善心功能。老年心力衰竭患者血清Ang-(1-7)水平与Ang II水平均升高,可能为机体及ACEI/ARB药物应用后的保护机制。 Objectiye To observe serum levels of Ang -(1 - 7)and AngⅡin Elderly Patients with Heart Failure. Methods A total number of 31 elderly patients with heart failure and 31 patients without heart failure as control group were enrolled in this study. The general data, laboratory data and UCG parameters were collected. The concentration of Ang -(1 - 7)and AngⅡ was detected by using ELISA. Results The serum concentration of Ang -(1 - 7)was significantly higher in patients with heart failure than those in control group(155. 50 ± 38. 28 pg/ ml vs. 130. 68 ± 32. 22 pg/ ml,P 〈 0. 05). The level of serum AngⅡwas significantly higher in patients with heart failure than those in control group;(1 346. 95 ± 236. 90 pg/ ml vs. 1 190. 17 ± 122. 52 pg/ ml,P 〈 0. 05). Conclusion Both serum Ang -(1 - 7)and Ang II levels were increased in elderly patients with heart failures,which indicate RAS system activation in heart failure. The elevation of serum Ang -(1 - 7)level might be protection caused by autoregulation and ACEI / ARB drugs using.
出处 《临床和实验医学杂志》 2016年第16期1569-1571,共3页 Journal of Clinical and Experimental Medicine
基金 北京市属医院科研培育计划项目(PX2016033)
关键词 老年人 心力衰竭 Ang-(1-7) AngⅡ Elderly Heart failure A ng- ( 1 - 7 ) Ang Ⅱ
  • 相关文献

参考文献4

二级参考文献51

  • 1廖玉华.心血管疾病免疫学研究进展[J].郑州大学学报(医学版),2005,40(2):181-183. 被引量:11
  • 2Nagatsu M, Spinale FG, Koide M, et al. Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction [ J ]. Circulation, 2000, 101 : 653-659.
  • 3Higaki J, Aoki M, Morishita R, et al. In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the athogenesis of cardiac hypertrophy [J]. Arterioscler Thromb Vasc Biol, 2000, 20: 428-434.
  • 4Sethi R, Shao Q, Ren B, et al. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin sys- tem[J]. Mol Cell Biochem, 2004, 263(1-2) :11-20.
  • 5Tsutsumi Y, Matsubara H, Ohkubo N, et al. Angiotensin Ⅱ type 2 receptor is upregulated in human heart with intersititial fibrosis, and cardiac fibroblasts are the major cell type for its expression [ J ]. Circ Res, 1998, 83 (10) : 1035- 1046.
  • 6Jalowy A, Schulz R, Dorge H, et aL Infarct size reduction by ATl-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and pmstaglandins in pigs[ J]. JACC, 1998,32(15) : 1787-1796.
  • 7Chrisa T, Stenaa B, Wendy B. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease [ J ]. Nephrol Hypertens, 2011,20( 1 ) :62-68.
  • 8de Mello WC. Novel aspects of angiotensin Ⅱ action in the heart. Implications to myocardial ischemia and heart failure[J]. Regul Pept, 2011, 166(1-17) :9- 14.
  • 9Verma S, Guptal M, Holmes DT. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study[ J]. Eur Heart J, 2011,32(17) : 2135-2142.
  • 10Sun Y, Zhang J, Zhang JQ, et al. Renin expression at site of repair in the in- farcted rat heart[ J]. J Mol Cell Cardiol, 2001, 33: 995-1003.

共引文献65

同被引文献58

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部